definiens: means the gross amounts invoiced or otherwise bil led by Sato or its Affiliates on account of sales or any other commerc ial disposition of the Licensed Product to Third Pa rties, including without limitation wholesalers, hospitals, distributors and/or other intermediate Third Part ies, in the Licensed Territory ( hereinafter the ), less the following to the extent specifically r elated to the Licensed Product and actually allowed, incurred or paid during such period according to Japanese GAAP : ( i ) [ * * * ] and [ * * * ], [ * * * ] and other [ * * * ] directly related to the sale to the extent applicable and not reimbursable, but [ * * * ] ; ( ii)amounts [ * * * ] or [ * * * ] ( including without limitation [ * * * ] and [ * * * ] ), [ * * * ], [ * * * ] or [ * * * ] with respect to the Licensed Product ; ( iii ) [ * * * ], [ * * * ], [ * * * ], [ * * * ] or [ * * * ] and [ * * * ] to the [ * * * ] ; ( iv)charges incurred in connection with the [ * * * ] or [ * * * ] of the Licensed Product, to the extent not deducted pursuant to sub section ( i ) or subsection ( iii ) above ; ( v ) [ * * * ] in connection with the Licensed Product ( it being understood that will include all amounts received for any [ * * * ] ) ; and ( vi ) [ * * * ] and [ * * * ] on account of the sale of the Licensed Product to the extent actually allowed and common within the pharmaceutic al industry in the Licensed Territory ; provided that all of the foregoing deductions are i ncurred in the ordinary course and calculated in accordance with Japanese GAAP, consistently applied, during the applicable calculation period througho ut the selling party ’s organization